4//SEC Filing
Dhanak Dashyant 4
Accession 0001209191-23-004558
CIK 0000879169other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:00 PM ET
Size
8.5 KB
Accession
0001209191-23-004558
Insider Transaction Report
Form 4
INCYTE CORPINCY
Dhanak Dashyant
EVP & Chief Scientific Officer
Transactions
- Award
Common Stock
2023-01-20+4,980→ 55,682 total - Award
Employee Stock Option (right to buy)
2023-01-20+16,128→ 16,128 totalExercise: $83.20Exp: 2033-01-19→ Common Stock (16,128 underlying)
Footnotes (3)
- [F1]Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on January 20, 2023. The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded.
- [F2]This includes an aggregate of 41,531 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. The aggregate amount also includes the additional Performance Stock Units earned on January 20, 2023.
- [F3]Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 and the remainder vesting monthly over three years.
Documents
Issuer
INCYTE CORP
CIK 0000879169
Entity typeother
Related Parties
1- filerCIK 0001760682
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:00 PM ET
- Size
- 8.5 KB